Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Diisopropyl Ether | HCID 7914 | — |
| Reactant | Sorafenib | HCID 216239 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 44599974 | HCID 44599974 | 73.8% |
Reaction Steps
Aqueous hydrogen bromide (15 mL) was added to a reaction vessel containing sorafenib free base (3.0 g) and the reaction mixture was stirred for about 5 minutes. The temperature was raised to about 70° C. The reaction mixture was stirred for about 2 hours. The solid was precipitated out. The reaction mixture was concentrated and purified by adding toluene (3×15 mL) and concentrated to obtain a solid. Ethanol (2 mL) was added. The reaction mixture was stirred for about 5 minutes followed by the addition of diisopropyl ether (5 mL). The solid was filtered and dried at about 50° C. for about 12 hours to obtain sorafenib hydrobromide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08614329B2 |
|---|
| Source dataset | uspto-grants-2013_12 |
|---|
| ORD ID | ord-ba6fcf30bce24f009ff6a277966f5c76 |
|---|
| Source note | uspto-grants-2013_12 |
|---|